Introducing ChemTides: Advancing Nucleic Acid Synthesis
Why ChemTides?
Scientific Update is proud to launch ChemTides, a brand-new international conference designed to become a leading forum for process chemists, and chemical engineers to discuss innovative synthetic methodologies for industrial scale synthesis of nucleosides, nucleotides and oligonucleotides.
The Focus?
The conference will emphasize innovations that enhance sustainability, scalability, and robustness in synthesis methodologies. We are inviting leading experts to present their work through case studies of large-scale process implementation and emerging synthetic methods with potential for sustainable industrial impact.
The Urgent Need!
Recent medical advancements have exposed a major bottleneck. While demand for nucleoside-containing pharmaceuticals is growing rapidly, current synthetic methods fall short—both in scale and sustainability. We will also host a Panel Discussion to talk about these issues:
Solid-phase oligonucleotide synthesis is typically capped at <10 kg per batch
Demand now exceeds multi-ton quantities
Waste is staggering—over 1,000 kg of waste per 1 kg of product
(R. Obexer et al., Science, 2024, 384 (6692), eadl4015. DOI)
ChemTides will bring together leading scientists to share solutions, breakthroughs, and vision for a more scalable and sustainable future in this space. Be part of the Inaugural ChemTides Conference and help shape the future of this vital field.
Join Us in Boston – March 16, 2026
ChemTides is co-located with the 7th Flow ÉîÒ¹¸£Àû¹ú²ú¾«Æ· Conference.
Why ChemTides?
Scientific Update is proud to launch ChemTides, a brand-new international conference designed to become a leading forum for process chemists, and chemical engineers to discuss innovative synthetic methodologies for industrial scale synthesis of nucleosides, nucleotides and oligonucleotides.
The Focus?
The conference will emphasize innovations that enhance sustainability, scalability, and robustness in synthesis methodologies. We are inviting leading experts to present their work through case studies of large-scale process implementation and emerging synthetic methods with potential for sustainable industrial impact.
The Urgent Need!
Recent medical advancements have exposed a major bottleneck. While demand for nucleoside-containing pharmaceuticals is growing rapidly, current synthetic methods fall short—both in scale and sustainability. We will also host a Panel Discussion to talk about these issues:
Solid-phase oligonucleotide synthesis is typically capped at <10 kg per batch
Demand now exceeds multi-ton quantities
Waste is staggering—over 1,000 kg of waste per 1 kg of product
(R. Obexer et al., Science, 2024, 384 (6692), eadl4015. DOI)
ChemTides will bring together leading scientists to share solutions, breakthroughs, and vision for a more scalable and sustainable future in this space. Be part of the Inaugural ChemTides Conference and help shape the future of this vital field.
Join Us in Boston – March 16, 2026
ChemTides is co-located with the 7th Flow ÉîÒ¹¸£Àû¹ú²ú¾«Æ· Conference.